{
  "name" : "twin.sci-hub.se_6335_f6c9b1ba2bbb8af7c1481eeb4a925fc9_hussein2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "The therapeutic effect of nano-encapsulated and nano-emulsion forms of carvacrol on experimental liver fibrosis",
    "authors" : [ "Jihan Hussein", "Mona El-Banna", "Khaled F. Mahmoud", "Safaa Morsy", "Yasmin Abdel Latif", "Dalia Medhat", "Eman Refaat", "Abdel Razik Farrag", "Sherien M. El-Daly" ],
    "emails" : [ "sm.el-daly@nrc.sci.eg,", "sherien_eldaly@yahoo.com" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Original article\nThe therapeutic effect of nano-encapsulated and nano-emulsion forms of carvacrol on experimental liver fibrosis\nJihan Husseina, Mona El-Bannaa, Khaled F. Mahmoudb, Safaa Morsya, Yasmin Abdel Latifa, Dalia Medhata, Eman Refaata, Abdel Razik Farragc, Sherien M. El-Dalya,* aMedical Biochemistry Department, Medical Division, National Research Centre, Dokki, Giza, Egypt1 b Technology Dept., National Research Centre (NRC), Dokki, Giza, Egypt c Pathology Department, National Research Centre, Dokki, Giza, Egypt1\nA R T I C L E I N F O\nArticle history: Received 8 January 2017 Received in revised form 29 March 2017 Accepted 10 April 2017\nKeywords: Liver fibrosis Carvacrol Nano-encapsulation Nano-emulsion Inflammation Oxidative stress Apoptosis\nA B S T R A C T\nObjective: The present study aimed to compare the therapeutic efficiency of nano-encapsulated and nano-emulsion carvacrol administration on liver injury in thioacetamide (TAA) treated rats. Methods: To fulfill our target, we used sixty male albino rats classified into six groups as follow: control, nano-encapsulated carvacrol, nano-emulsion carvacrol, thioacetamide, treated nano-encapsulated carvacrol and treated nano-emulsion carvacrol groups. Blood samples were collected from all groups and the separated serum was used for analysis of the following biochemical parameters; aspartate aminotransferase (AST), alanine aminotransferase (ALT), S100 B protein, alpha fetoprotein (AFP) and caspase-3. The levels of malondialdehyde (MDA), reduced glutathione (GSH), nitric oxide (NO), monocyte chemoattractant protein-1(MCP-1) and hydroxyproline content were all evaluated in liver tissue homogenate. Histopathological examinations for liver tissues were also performed. Results: Thioacetamide induced hepatic damage in rats as revealed by the significant increase in the levels of serum ALT, AST and produced oxidative stress as displayed by the significant elevation in the levels of hepatic MDA and NO concomitant with a significant decrease in GSH. In addition, thioacetamide significantly increased serum S100B protein, alpha fetoprotein and caspase-3 along with hepatic MCP-1 and hydroxyproline; these results were confirmed by the histopathological investigation. In contrast, nano-encapsulated and nano-emulsion carvacrol were able to ameliorate these negative changes in the thioacetamide injected rats. However, the effect of the nano-encapsulated form of carvacrol was more prominent than the nano-emulsion form. Conclusion: Nano-encapsulated and nano-emulsion carvacrol can ameliorate thioacetamide induced liver injury. These results could be attributed to the potential anti-inflammatory, antioxidant, and antiapoptotic activities of carvacrol in addition to the effectiveness of the encapsulation technique that can protect carvacrol structure and increase its efficiency and stability. Moreover, nano-encapsulation of carvacrol is more efficient than nano-emulsion.\n© 2017 Elsevier Masson SAS. All rights reserved.\nAvailable online at\nScienceDirect www.sciencedirect.com"
    }, {
      "heading" : "1. Introduction",
      "text" : "Liver fibrosis is considered as a serious health problem due to the prominent role of liver as an organ in different physiological\n* Corresponding author at: Department of Medical Biochemistry, Medical Division, National Research Centre. Address: 33 El Buhouth St. Dokki, 12622, Cairo, Egypt.\nE-mail addresses: sm.el-daly@nrc.sci.eg, sherien_eldaly@yahoo.com (S.M. El-Daly).\n1 (Affiliation I D: 60014618).\nhttp://dx.doi.org/10.1016/j.biopha.2017.04.020 0753-3322/© 2017 Elsevier Masson SAS. All rights reserved.\nprocesses such as metabolism and detoxification of a variety of drugs and xenobiotics [1]. Fibrosis is a result of the inadequate tissue repair mechanism that occur following chronic liver injuries including alcohol induced damage, chronic viral hepatitis B or C, parasitic and metabolic diseases [2]. If fibrosis is not controlled, it can further be developed into cirrhosis, which eventually ends up with hepatic failure [3].\nThioacetamide (TAA) is a well-documented agent that liberates free radicals [4] and is considered as a potent toxic agent for studies concerning the pathogenesis of hepatic fibrosis [4,5]. TAA can effectively induce hyperplastic liver nodules, cell adenomas that\ncould progress into hepatocarcinomas [6]. Therefore, TAA induced liver fibrosis is a successful experimental model that can be used to study the pathogenesis of hepatic fibrosis.\nSeveral medical reports have stated that tissue transplantation could be the only effective treatment available till now to manage liver fibrosis, however, the continuous progress in studying the biological activities of natural products and herbs have shed light on their potential use for treating hepatic fibrosis [7].\nCarvacrol is a monoterpenoid phenol found in several aromatic plants including oregano (Origanum vulgare), pepperwort (Lepidium flavum), thyme (Thymus vulgaris) and wild bergamot. Several in vivo and in vitro studies illustrated the various bioactivity and toxicological properties of carvacrol nutrient including its antibacterial, antiseptic, antispasmodic, antioxidant, antifungal, and antiviral properties. Moreover, carvacrol has also been reported to have anti-inflammatory, immunomodulatory and chemopreventive properteis [8,9]. Carvacrol is highly lipophilic with low solubility in water [10], high volatile, and with strong odor of essential oil. All these characteristics are the main reasons that make it difficult to be applied in food industry [11].\ncarvacrol (2-methyl-5-(1-methylethyl)-phenol). Encapsulation of phytochemicals is one of the most important and interesting applications that enhances their bioavailability by changing the pharmacokinetics and bio-distribution [12] and thus alleviate the drawbacks of their instability, unpleasant flavor or taste and most importantly improve the bioavailability and halflife of the compound through protection of the active compounds against environmental factors (e.g, oxygen, light, moisture, and pH) [13]. Nanotechnology is used for the production of new nutrition delivery systems to improve quality of food needs. Recent efforts have led to delivery systems in micro- and nanoscale so that the particular functionality of them has been illustrated based on nanonutrition delivery systems using various natural and synthetic materials [14]. In a previous work by Mahmoud et al. [15] the nanoencapsulation deliver system of the essential oil eugenol significantly improved the stability along with the antioxidant and antimicrobial activity of this essential oil comparing to its original form.\nNanoemulsions can be prepared with different materials depending on the desire structure and functionality by using high energy procedures (high pressure homogenization, ultrasonication, and microfluidization) or low energy techniques (solvent diffusion). High-energy methods produce intense disruptive forces minimizing droplet size to form emulsions, while low energy methods promote spontaneous emulsification by mixing all the emulsion ingredients [16]. Among the most used nanoemulsions; (a) oil in water (O/W) procedure where the droplets of oil are dispersed in an aqueous phase and the interphase is stabilized by emulsifiers, (b) the multiple emulsions procedure oil-in-water-inoil (O/W/O) or water-in-oil-in-water (W/O/W) where for example, minute water droplets immersed inside large oil droplets are in turn dispersed within another aqueous phase; and (c) the multilayer emulsions which is formed as oil droplets surrounded with nanometric size layers of different polyelectrolytes [17].\nWith the obvious lack of a clinically effective therapy for liver fibrosis, and with the increasing interest of enhancing the\nefficiency and stability of compounds through nano-formulations, we were interested to investigate whether nano-encapsulated and/or nano-emulsion carvacrol could be a potential therapeutic candidate for fibrotic liver diseases. We aimed in this study to compare between the therapeutic efficiency of two different delivery systems of carvacrol (nano-encapsulated and nanoemulsion forms) on thioacetamide induced liver fibrosis."
    }, {
      "heading" : "2. Materials and methods",
      "text" : ""
    }, {
      "heading" : "2.1. Materials",
      "text" : ""
    }, {
      "heading" : "2.1.1. Chemicals",
      "text" : "Pure bioactive compound carvacrol and thioacetamide were purchased from Sigma Aldrich Chemicals Company (St Louis, Missouri, USA)."
    }, {
      "heading" : "2.1.2. Experimental animals",
      "text" : "Sixty male albino rats weighing (180–200 g) used in this study were obtained from the animal house of the National Research Centre (Giza, Egypt), and they were housed in stainless steel cages under environmentally controlled conditions. The ambient temperature was 25 2 C and the light/dark cycle was 12/12 h. The animals had free access to water and standard rodent chow diet. All animals received human care in compliance with guidelines of the Ethical Committee of National Research Centre, Egypt."
    }, {
      "heading" : "2.2. Methods",
      "text" : ""
    }, {
      "heading" : "2.2.1. Preparation of carvacrol oil formulations",
      "text" : "The nano forms of carvacrol oil were prepared according to the method of Mahmoud et al. [15] with some modifications.\n2.2.1.1. Nano-encapsulation of carvacrol. In the current investigation, nano-encapsulation of carvacrol was carried out according to the modified method of Mahmoud et al. [15] and Terjung, et al. [18] using homogenization model in a matrix comprising of maltodextrin and Tween 20 (T20).\nMaltodextrin was dissolved in de-ionized water (10 g/100 ml) to which carvacrol and an emulsifier Tween 20 were added to a final concentration of 150 ml. Optimization of batch size and process parameters were set through several experimental trials. The proportion of carvacrol: maltodextrin: T20 was varied during preliminary trials and it was found that the ratio of 3:10:1 gave optimum yield of powder with desirable attributes. Three grams of carvacrol oil were added to 150 ml solution containing 10 g maltodextrin and 1% T20. The emulsion was created by mixing the solution in a high-pressure homogenizer (Homogenizer PRO 400 PC, Germany) at 18.000 rpm for 30 min. The temperature was kept at 35 C. The mixture solution obtained was flushed with nitrogen and stored in sealed glass jar at 4 C until used.\n2.2.1.2. Nano-emulsion of carvacrol. The carvacrol oil-in-water nanoemulsions (O/W) were prepared using a high pressure homogenization (HPH) technique with 1% T20 added to the formulation to stabilize the mixture. Primary emulsion containing 3 g carvacrol oil was dissolved in 150 ml deionised water containing 1% T20. The emulsion was created by mixing the solution that was obtained by High Shear Homogenization (HSH), using an Ultra-Turrax T25 (IKA Labortechnik, Germany) at 24000 rpm for 10 min. The primary emulsions were then subjected to HPH in a Nano DeBEE Electric Bench-top Laboratory homogenizer (BEE International, USA) 10 times at 350 MPa. When T20 was used as an aqueous phase, the carvacrol was dissolved in water and the temperature during processing was\nalways kept around 5–10 C above the oil melting point. Crystallization of the mixture droplets was attained by rapid cooling of the hot nanoemulsions in an ice bath at the end of the HPH processing [19].\n2.2.1.2.1. Determination of encapsulation efficiency (EE) and loading capacity (LC). The Encapsulation Efficiency and loading capacity of the nanoparticles (nano-emulsion and nano-encapsulated carvacrol) were estimated based on the method and equations of Keawchaoon and Yoksan [20] with some modifications.\nThe Encapsulation Efficiency (EE) was determined by the separation of nanoparticles from the aqueous medium containing free carvcrol oil. About 1 ml of carvacrol-loaded maltodextrin solution was centrifuged at 9000 rpm for 30 min, then 1 ml of ethanol solution (99%) was added to the pellet in scrap cap tube and incubated at 30 C and 500 rpm for 24 h. Sample was centrifuged (9000 rpm, 25 C and 30 min) and the resulting solution was filtered with a pore size 0.2 mm. The amount of carvacrol oil in the supernatant was measured by a spectrophotometer at 274 nm. Carvacrol concentration was calculated using a standard curve by plotting the absorbance of carvacrol against its concentration at 275 nm. Loading capacity (LC) of nano-emulsion and nano-encapsulated carvacrol loaded in maltodextrin was determined through thermogravimetric (TGA/DTG) technique.\nEE% ¼ Total amount of carvacrol oil free carvacrol oil after separation Total amount of carvacrol oil\n100 ð1Þ\nLC% ¼ Total amount of carvacrol oil free carvacrol oil after separation Weight mass formula\n100 ð2Þ"
    }, {
      "heading" : "2.2.2. Estimation of total antioxidant activity",
      "text" : "The total antioxidant activity of nano-encapsulated and nanoemulsion carvacrol in comparison with free carvacrol oil was determined according to the method of Mahmoud et al. [15].\n2.2.3. Induction of liver fibrosis Liver fibrosis was induced in albino rats by intraperitoneal injection of thioacetamide (TAA) in a dose of 150 mg/kg body weight twice a week for 6 weeks as described previously [21]. Before proceeding to treatment, three rats were used for liver histopathology examination to confirm induction of liver fibrosis."
    }, {
      "heading" : "2.2.4. Experimental design",
      "text" : "Male albino rats were used in this study and divided into six groups (10 rats/group) as follows: Group I (control group): healthy rats received a vehicle. Group II (nano-emulsion carvacrol group): healthy rats received nano-emulsion of carvacrol (20 ml/kg body weight/day) orally for 7 days [22].\nGroup III (nano-encapsulated carvacrol group): healthy rats received nano-encapsulated of carvacrol 20 ml/kg body weight/day orally for 7 days [22].\nGroup IV (thioacetamide group): rats injected with TAA for induction of liver fibrosis.\nGroup V (treated nano-emulsion carvacrol): rats received nanoemulsion of carvacrol (20 ml/ kg body weight/day) orally for 7 days after induction of liver fibrosis.\nGroup VI (treated nano-encapsulated carvacrol): rats received nano- encapsulated of carvacrol 20 ml/kg body weight/day orally for 7 days after induction of liver fibrosis.\nNote: The dose of nano-encapsulated or nano-emulsion Carvacrol (20 ml/kg body weight) equals to 0.4 mg Carvacrol/kg body weight."
    }, {
      "heading" : "2.2.5. Blood sampling",
      "text" : "At the end of the experimental period, rats were kept fasting for 12 h before blood sampling, blood samples were withdrawn from the retro-orbital plexus vein under light anesthesia. Serum was separated by centrifugation for 15 min at 3000 rpm and then divided into aliquots and stored at 20 C for further biochemical analysis."
    }, {
      "heading" : "2.2.6. Tissue sampling",
      "text" : "Rats were sacrificed by decapitation, liver was removed quickly from each rat and perfused with iced phosphate-buffered saline (PBS) [pH = 7.4] to remove blood. Each liver was isolated and divided into two equal parts, the first part was used for histopathological examination and the second part was homogenized for biochemical parameters estimation.\n2.2.6.1. Histopathological studies. liver was fixed immediately in 10% neutral buffered formalin for 24 h; the specimens were washed in tap water, dehydrated in ascending grades of ethanol, cleared in xylene and embedded in paraffin wax. Sections of 6 mm thickness were prepared and stained with Haematoxylin and Eosin [23]. Stained liver sections were examined by light microscope.\n2.2.6.2. Tissue homogenate. The second part of liver tissue was cut into small pieces and homogenized in 5 ml cold buffer (0.5 g of Na2HPO4 and 0.7 g of NaH2PO4 per 500 ml deionized water (pH 7.4) per gram tissue) then centrifuged at 4000 rpm for 15 min at 4 C [24]. The supernatant was removed for estimation of different biochemical parameters."
    }, {
      "heading" : "2.2.7. Biochemical analysis",
      "text" : "Serum alanine amino transferase (ALT) and aspartate amino transferase (AST) were determined using commercial kit purchased from BioMed Diagnostics based on the method described by Reitman and Frankel [25]. Liver homogenates were used for estimation of the levels of malondialdehyde (MDA), reduced glutathione (GSH) and nitric oxide (NO) according to the methods of Watanabe et al. [26], Nakano et al. [27] and Moshage et al. [28] respectively. Serum S100 calcium-binding protein B (S100B) was estimated by enzyme-linked immunosorbant assay (ELISA), the kit was purchased from (Dia Sorin, USA) based on the method of Gao et al. [29]. Serum Alpha fetoprotein (AFP) was measured using DRG1 AFP ELISA Kit (DRG International Inc, Cat.EIA-1468) according to the method of Hirai [30]. Serum caspase 3 was analyzed by ELISA technique using commercial kits from R&D Systems GmbH (Wiesbaden, Germany).\nLiver monocyte chemoattractant protein-1 (MCP-1) was estimated in the supernatants using the sandwich-type immunoassay kit (R&D Systems, Minneapolis, MN) according to the manufacturer’s instructions.\n2.2.7.1. Hydroxyproline (Hyp) assay. A colorimetric assay was performed according to the method of Patiyal and Katoch [31] for estimation of hydroxyproline content. Briefly, liver sections (0.5 g) were hydrolyzed (20 h in 6 mol/L HCl at 100 C), dissolved in ultrapure water and centrifuged to remove any impurities. Samples were incubated for 10 min in 0.05 mol/L chloramine-T (Fisher, Fair Lawn, NJ, USA) at room temperature, followed by 15 min incubation in Ehrlich'sperchloric acid solution at 65 C. Sample absorbance was measured at 561 nm and the value for each sample was calculated from a hydroxyproline standard curve."
    }, {
      "heading" : "2.2.8. Statistical analysis",
      "text" : "In the present study, we used statistical package for social science (SPSS software version 12, Chicago, Illinois) on a personal computer. All numeric variables were expressed as mean standard error (SE) and analyzed by one-way analysis of variance (ANOVA) followed by Duncan’s multiple range test for post-hoc comparison of group means. For all tests a probability (P < 0.05) was considered significant."
    }, {
      "heading" : "3. Results",
      "text" : "3.1. Encapsulation efficiency (EE) and loading capacity (LC) of carvacrol\nLoading capacity of carvacrol was estimated from absorbance at 275 nm. The weight ratio of maltodextrin to carvacrol was 3:10 in nano-encapsulated formula. EE and LC of nanoparticles prepared through desolvation/encapsulation method were found to be 76.4 and 69.2%, respectively (Table 1). However, nanoparticles prepared by desolvation/emulsion method had EE% and LC% of 49.3 and 48.7%, respectively.\nAlthough, addition of carvacrol into the polymer–surfactant solution in desolvation/emulsion procedure decreased the percentage of EE, but no remarkable change was reported in the yield of nanoparticles in both formulations. The encapsulation of carvacrol increased the efficiency as bioactive ingredients."
    }, {
      "heading" : "3.2. Effect of pH and temperature on stability of the different forms of cavacrol",
      "text" : "The effect of pH and temperature on antioxidant stability of free, nano-emulsion and nano-encapsulated carvacrol oil has been studied by estimating antioxidant activity of carvacrol oil at 0.5 mg/ml concentration.\nExperiment was carried out by exposing free, nano-emulsion and nano-encapsulated carvacrol individually in buffer solutions with different pH (4, 7 and 10) for 2 h separately and for temperature stability the free carvacrol, nano-emulsion and nano-encapsulated forms were exposed to different temperatures (37, 50 and 70 C) separately in buffer solution for 2 h. After that the antioxidant activity of carvacrol has been estimated.\nThe results showed that the change in pH either from acidic to alkaline and the increase in temperature enhanced the loss of the\nantioxidant activity of free carvacrol oil, which was not the case with nano-emulsion and nano-encapsulated carvacrol (Table 2). The results imply the ability of the packaging material (maltodextrin) to protect the nano-emulsion and nano-encapsulated forms of carvacrol from the changes in degree of acidity and temperature efficiently than the free form carvacrol. Therefore we speculated that these nano-forms are worth to be applied and tested in vivo instead of the free form since they would be more stable."
    }, {
      "heading" : "3.3. Biochemical analysis",
      "text" : "In the present study it was found that, AST and ALT levels were insignificantly changed in normal groups treated with nanoemulsion or nano-encapsulated carvacrol compared to the control group indicating the safety of the supplemented nanoparticles. On the other hand, the mean values of AST and ALT levels were significantly increased in rats treated with thioacetamide (TAA group) comparing to the control group. However, these values were significantly decreased by the administration of nanoemulsion or nano-encapsulated carvacrol in treated groups compared to thioacetamide group (Table 3).\nLiver MDA and NO were significantly increased, while GSH was significantly decreased in thioacetamide group compared to control, indicating the elevation of oxidative stress. On the other hand, liver MDA and NO were significantly decreased, while GSH was significantly increased in nano-emulsion and nano-encapsulated carvacrol treated groups comparing to TAA group (Table 3), indicating the antioxidant potential of these supplemented agents.\nIn addition, the detected elevation in the levels of liver MCP-1 and hydroxylproline in TAA group were found to be significantly reduced in groups treated with TAA and then supplemented with nano-emulsion or nano-encapsulated carvacrol (Table 4). MCP-1 level in nano-emulsion carvacrol treated group was still significantly high comparing to control group; however in nanoencapsulated carvacrol treated group it became more or less near the control group, indicating the better effect of nano-encapsulated carvacrol (Table 5).\nOther findings in our study were the elevation of serum AFP, Caspase 3 and S100 P levels in TAA group in comparison with control group. However, the values of these parameters were significantly decreased in both nano-emulsion and nano-encapsulated carvacrol treated groups compared to TAA group. The levels\nof these parameters in treated nano-emulsion carvacrol group were still significantly high comparing to control group, however in treated nano-encapsulated group they become more or less near the control group. On the other hand, no significant difference was observed between both treated groups (Table 6)."
    }, {
      "heading" : "3.4. Histopathological results",
      "text" : "The histological examination showed a normal pathology of hepatic lobules in the control group where hepatocytes assembled as plates radiating from the central veins, with narrow vascular sinusoids and prominent nucleus (Fig. 1A). Microscopic liver examination of normal rats received nano-emulsion or nanoencapsulated carvacrol also showed normal histological structure of hepatic parenchyma, where the central veins and hepatocytes exhibited normal form (Fig. 1B and C).\nHowever, histopathological investigation of thioacetamide group showed disarrangement of hepatic cells associated with abnormal architecture of hepatic parenchyma, collagen deposition in portal tract, and formation of pseudo-lobules surrounded by\nfibrous tissues (Fig. 1D). Thick fibrosis strands and large hemorrhagic area were also detected (Fig. 1E).\nIn treated nano-emulsion carvacrol group, pathological examination of liver tissue showed vacuolated cytoplasm and congested hepatic sinusoids (Fig. 2A), the hepatic lobule appeared slightly like normal in few samples of this group (Fig. 2B). The same was also detected in liver tissue sections of treated nano-encapsulated carvacrol group, where the hepatic lobule appeared more or less like normal (Fig. 2C), in some liver tissue sections of this group activated Kupffer cells were detected (Fig. 2D)."
    }, {
      "heading" : "4. Discussion",
      "text" : "Phytochemical's encapsulation is an interesting application that enhances their bioavailability by improving the pharmacokinetics and bio-distribution over free compounds and overcoming the drawbacks of instability [32]. Development of encapsulation of essential oils using porous materials and lipid solidification has lead to the following main findings:\n1. Essential oils (EOs) with low water solubility (carvacrol as an example) can be efficiently encapsulated with a high EE% and LC % through single extrusion method using alginate as a delivering material. EOs with moderate water solubility such as cinnamaldehyde can be effectively absorbed in porous polymers and then encapsulated by applying second coating [33]. 2. Nanoencapsulation of carvacrol by maltodextrin (as in our case) has not suppressed its antimicrobial activity. The minimum bactericidal concentration (MBC) was found identical for encapsulated and non-encapsulated carvacrol when tested in culture medium and in simulated gastrointestinal model [34]. 3. Nanoencapsulation technique could effectively prevent the loss of EOs in the upper gastrointestinal tract thus increase the proportion of delivered EOs, therefore encapsulated carvacrol can be released nearly completely in the small intestine [35].\nIn our study and continuing the work of Mahmoud et al. [15] who were able to prepare both nano-emulsion and nanoencapsulated forms of carvacrol with high encapsulation efficiency and loading capacity and we then investigated their potential therapeutic effect on TAA induced liver fibrosis model.\nTAA induced liver fibrosis in rodents is a documented model with morphological, physiological and biochemical changes similar to human fibrosis [36] and sometimes it induces cirrhosis [21].\nIn the present study, TAA injection significantly increased liver enzymes (ALT and AST) in the blood stream which may be related to the leakage of these enzymes from the liver cytosol as a result of alteration in their membrane permeability and transport functions [37]. At the same time, a marked increase in the levels of liver MDA and NO were also observed concomitant with a reduction in GSH\ncontent in the TAA group. The elevation of MDA due to increased lipid peroxidation and oxidative stress is a logical explanation of TAA-induced liver injury in our study. In addition, several studies indicated that increased oxidative stress and reactive oxygen species (ROS) signaling cascade is associated with the activation of hepatic stellate cells (HSC's) [38] that produce ROS as well [39].\nBesides ROS, nitric oxide (NO) represents another active radical which is synthesized by nitric oxide synthase (NOS). The expression of inducible nitric oxide synthase (iNOS) is observed in liver injury, inflammation and fibrosis [40]. NO has the ability to react with ROS forming peroxynitrite, a very toxic and oxidizing agent that induce DNA damage and lipid peroxidation [41].\nAnother finding in our study following TAA-induced liver injury is the elevation of S100 calcium-binding protein B (S100B) which is intracellular localized in the cytoplasm and nucleus, whereas it is secreted from epithelial-like cells and tumor cells to increase cellular proliferation and formation of ROS [42] and regulation of inflammatory responses [43], thus S100 B proteins could play an important role in inflammation [44]. Inflammation is also confirmed in our work following TAA administration by the elevation of MCP-1, which is one of the key chemokines that could potentially regulate migration and infiltration of monocytes/ macrophages to certain organ in response to inflammation [45]. In the liver, increased MCP-1 expression has been reported in\npatients with acute and chronic inflammatory diseases and in rodent model liver of injury [46]. In agreement with our result, Mori et al. [47] indicated that MCP-1 mRNA was highly expressed in TAA induced liver injury rat model, suggesting that the increase of MCP-1 at early stages could prompt macrophage infiltration into injured areas. In addition to the chemotaxis effect, MCP-1 also plays an important role in fibrogenesis [48]. Another important characteristic of liver fibrosis and cirrhosis is the accumulation of extracellular matrix proteins, particularly collagen [49], and this could explain the significant elevation that we detected in the levels of hydroxyproline, the amino acid unique to all collagens, in our TAA injected model. This was also associated with elevation of alpha fetoprotein (AFP), the well known liver inflammation and fibrosis marker and also tumor marker of hepatocellular carcinoma (HCC) [50].\nThe treatment with nano-emulsion or nano-encapsulated carvacrol in this study was also able to ameliorate the significant detected elevation of liver enzymes and hepatotoxicity, demonstrating potential effect of this monoterpenic phenol against hepatic damage induced by TAA. Attenuation of oxidative stress parameters (MDA and NO) and elevation of the anti-oxidant parameter GSH by either nano-emulsion or nano-encapsulated carvacrol support the hypothesis that these 2 forms of carvacrol nanoparticles could potentially ameliorate liver injury through its\nantioxidant properties [51]. It has been previously reported that carvacrol could effectively scavenge superoxide radicals and H2O2 and therefore increase antioxidant enzymes and decrease the free radical mediated inactivation of enzyme proteins and thus maintain the activity of endogenous antioxidant enzyme and improve GSH level [8].\nBeside the antioxidant properties of carvacrol, it is also characterized by anti-inflammatory properties that was detected in the present study by the significant reduction in the levels of MCP-1, S100-B, and AFP in both treated groups, suggesting the potential anti-inflammatory efficiency of both carvacrol nanoforms. Carvacrol has been previously reported to have antiinflammatory effects by reducing the production of inflammatory mediators such as IL-1a and prostanoids [9]. Kim et al. [52] confirmed these results and indicated that carvacrol mediated reduction in the expression of pro-inflammatory cytokines and plasma MCP1 and TNF-a concentrations in the liver of mice fed with high-fat diet which may be contributed to decreased infiltration of macrophage into the liver.\nIn the present study nano-emulsion and nano-encapsulated carvacrol also protected the liver from fibrogenesis caused by TAA through the significant reduction of the mean value of hepatic hydroxyproline in both treated groups.\nUncontrolled liver injury leading to fibrosis is characterized by enhancement in the apoptotic death of hepatocytes [53], this was supported in our study by the significant elevation in the level of caspase-3 in TAA injected group comparing to control group. However, treatment with nano-emulsion or nano-encapsulated carvacrol was able to suppress this elevation. In agreement with our result, Nafees et al. [54] also reported that carvacrol prevented the elevation in apoptosis induced by TAA administration; through pretreatment with carvacrol that showed a protective effect against the deteriorative effect of TAA through reducing oxidative stress, inflammation and apoptosis.\nThe reduction of AFP and caspase-3 in the two treated groups in our work could be a sign of a potential antitumor efficiency of carvacrol. In agreement, Subramaniyan et al. [55] also reported a\npotential anti-carcinogenic efficiency of carvacrol through inhibiting cell proliferation and preventing metastasis in diethylnitrosamine- induced hepatocellular carcinomas.\nIn conclusion our results revealed that; the process of nanoemulsion or nano-encapsulation of carvacrol which is a potential modality to enhance the bioavailability and overcome any drawbacks of carvacrol application in the medical sector could be effectively used in the medical sector. Through using the TAA experimental model of liver fibrosis, we were also able to prove that using the nano-emulsion or nano-encapsulated forms of carvacrol efficiently attenuated liver fibrosis through an antiinflammatory and anti-oxidant effect. It is also worth to mention that, most of our measured biochemical parameters were almost near the control group when using the nano-encapsulated form of carvacrol rather than the nano-emulsion form, indicating that the efficiency of nano-encapsulated carvacrol exceeds that of nanoemulsion. Therefore, our study suggests that nano-encapsulated carvacrol could be used as a promising agent protecting against liver fibrosis."
    } ],
    "references" : [ {
      "title" : "Antihepatotoxic activity of smilax china roots on CCl4 induced hepatic damage in rats",
      "author" : [ "S.B.G. Raju", "R.G. Battu", "Y.B. Manju latha", "K. Srinivas" ],
      "venue" : "Int. J. Pharm. Pharm. Sci",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2012
    }, {
      "title" : "Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches",
      "author" : [ "E. Mormone", "J. George", "N. Nieto" ],
      "venue" : "Chem. Biol. Interact. 193 ",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Technology insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography",
      "author" : [ "M. Pinzani", "F. Vizzutti", "U. Arena", "F. Marra" ],
      "venue" : "Nat. Clin. Pract. Gastroenterol. Hepatol. 5 ",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "The effect of antidepressant drugs on thioacetamide-induced oxidative stress",
      "author" : [ "O.M. Abdel Salam", "N.A. Mohammed", "A.A. Sleem", "A.R. Farrag" ],
      "venue" : "Eur. Rev. Med. Pharmacol. Sci. 7 ",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Emergence of different macrophage populations in hepatic fibrosis following thioacetamide-induced acute hepatocyte injury in rats",
      "author" : [ "M. Ide", "J. Yamate", "Y. Machida", "M. Nakanishi", "M. Kuwamura", "T. Kotani", "O. Sawamoto" ],
      "venue" : "J. Comp. Pathol. 128 ",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma",
      "author" : [ "C.N. Yeh", "A. Maitra", "K.F. Lee", "Y.Y. Jan", "M.F. Chen" ],
      "venue" : "Carcinogenesis 25 (2004) 631–636.  J. Hussein et al. / Biomedicine & Pharmacotherapy 90 ",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Potent natural products and herbal medicines for treating liver fibrosis",
      "author" : [ "S.R. Chen", "X.P. Chen", "J.J. Lu", "Y. Wang", "Y.T. Wang" ],
      "venue" : "Chin. Med. 15 (10) ",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Carvacrol modulates oxidative stress and decreases cell injury in pancreas of rats with acute pancreatitis",
      "author" : [ "Y. Kılıç", "F. Geyikoglu", "S. Çolak", "H. Turkez", "M. Bakır", "M. Hsseinigouzdagani" ],
      "venue" : "Cytotechnology 68 ",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Anti-inflammatory effects of carvacrol: evidence for a key role of interleukin-10",
      "author" : [ "M.D. Lima", "L.J. Quintans-Junior", "W.A. de Santana", "C. Martins Kaneto", "M.B. Pereira Soares", "C.F. Villarreal" ],
      "venue" : "Eur. J. Pharmacol",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2012
    }, {
      "title" : "Antimicrobial activity of carvacrol toward Bacillus cereus on rice",
      "author" : [ "A. Ultee", "R.A. Slump", "G. Steging", "E.J. Smid" ],
      "venue" : "J. Food Prot. 63 ",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "Physical and antimicrobial properties of peppermint oil nanoemulsions",
      "author" : [ "R. Liang", "S. Xu", "C.F. Shoemaker", "Y. Li", "F. Zhong", "Q. Huang" ],
      "venue" : "J. Agric. Food Chem. 60 ",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Bioavailability and delivery of nutraceuticals using nanotechnology",
      "author" : [ "Q. Huang", "H. Yu", "Q. Ru" ],
      "venue" : "J. Food Sci. 75 ",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Nano- and micro-structured assemblies for encapsulation of food ingredients",
      "author" : [ "M.A. Augustin", "Y. Hemar" ],
      "venue" : "Chem. Soc. Rev. 38 ",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Encapsulation of health-promoting ingredients: applications in foodstuffs",
      "author" : [ "R. Tolve", "F. Galgano", "M.C. Caruso", "F.L. Tchuenbou-Magaia", "N. Condelli", "F. Favati", "Z. Zhang" ],
      "venue" : "Int. J. Food Sci. Nutr. 67 ",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Nanoencapsulation and nanoemulsion of bioactive compounds to enhance their antioxidant activity in food",
      "author" : [ "K.F. Mahmoud", "K.M. Ramadan", "I.S. Ashoush" ],
      "venue" : "IJFST 4 ",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "A novel active bionanocomposite film incorporating rosemary essential oil and nanoclay into chitosan",
      "author" : [ "M. Abdollahi", "M. Rezaei", "G. Farzi" ],
      "venue" : "J. Food Eng. 111 ",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Physico-mechanical properties of chitosan films with carvacrol and grape seed extract",
      "author" : [ "J.F. Rubilar", "R.M.S. Cruz", "H.D. Silva", "A.A. Vicente", "I. Khmelinskii", "M.C. Vieira" ],
      "venue" : "J. Food Eng. 115 ",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Influence of droplet size on the efficacy of oil-in-water emulsions loaded with phenolic antimicrobials",
      "author" : [ "N. Terjung", "M. Loffler", "M. Gibis", "J. Hinrichs", "J. Weiss" ],
      "venue" : "Food Funct. 3 ",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Essential oil formulations useful as a new tool for insect pest control",
      "author" : [ "M.D. Moretti", "G. Sanna-Passino", "S. Demontis", "E. Bazzoni" ],
      "venue" : "AAPS PharmSciTech 3 ",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Preparation",
      "author" : [ "L. Keawchaoon", "R. Yoksan" ],
      "venue" : "characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles, Colloids Surf. B Biointerfaces 1 (84 (1)) ",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Mesenchymal stem cells therapy for thioacetamide induced liver cirrhosis",
      "author" : [ "Z. El-khayat", "E. Mostafa", "J. Hussein", "M. El-waseef", "L.A.R. Rashed Farrag", "D. Medhat" ],
      "venue" : "Int. J. Pharm. Pharm. Sci. 5 ",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "K",
      "author" : [ "S. Jayakumar", "A. Madankumar", "S. Asokkumar", "S. Raghunandhakumar" ],
      "venue" : "Gokula dhas, S. Kamaraj, M.G. Divya, T. Devaki, Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats, Mol. Cell. Biochem. 360 ",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Theory and Practice of Histological Techniques",
      "author" : [ "J.D. Bancroft", "M. Gamble" ],
      "venue" : "5th ed., Churchill Livingstone, Edinburgh, London",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Saccharomyces cerevisiae intervension for relieving flutamide-induced hepatotoxicity in male rats",
      "author" : [ "F. Manna", "H.H. Ahmed", "S.F. Estefan", "H.A. Sharaf", "E.F. Eskander" ],
      "venue" : "Pharmazie 60 ",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases",
      "author" : [ "S. Reitman", "S. Frankel" ],
      "venue" : "Am. J. Clin. Pathol. 28 ",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 1957
    }, {
      "title" : "FR167653 improves survival and pulmonary injury after partial hepatectomy under ischemia/ reperfusion in rats",
      "author" : [ "M. Watanabe", "K. Yamaguchi", "K. Chijiiwa", "M. Tanaka" ],
      "venue" : "J. Surg. Res. 101 ",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2001
    }, {
      "title" : "S-adenosyl-L-methionine attenuates ischemia-reperfusion injury of steatotic livers",
      "author" : [ "H. Nakano", "M. Yamaguchi", "Y. Kaneshiro", "K. Yoshida", "G. Kigawa", "H. Nagasaki", "Y. Fujiwara", "F. Matsumoto", "N. Kitamura", "J. Sasaki", "M. Kuzume", "S. Takeuchi", "K. Kumada" ],
      "venue" : "Transplant. Proc. 30 ",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 1998
    }, {
      "title" : "Nitrite and nitrate determination in plasma: a critical evaluation",
      "author" : [ "H. Moshage", "B. Kok", "J.R. Huizenga" ],
      "venue" : "Clin. Chem. 41 ",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 1995
    }, {
      "title" : "Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: part I-the effects of heparin protamine and propofol",
      "author" : [ "F. Gao", "D.N.F. Harris", "S. Sapsed-Byrne" ],
      "venue" : "Perfusion 12 ",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 1997
    }, {
      "title" : "Alpha fetoprotein",
      "author" : [ "H. Hirai" ],
      "venue" : "in: T.M. Chu (Ed.), Biochemical Markers for Cancer, Marcel Dekker, New York",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 1982
    }, {
      "title" : "katoch, Tissue specific and variable collagen proliferation in Swiss Albino mice treated with clenbuterol",
      "author" : [ "S.S.S.N. Patiyal" ],
      "venue" : "Physiol. Res",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2006
    }, {
      "title" : "Nano- and micro-structured assemblies for encapsulation of food ingredients",
      "author" : [ "M.A. Augustin", "Y. Hemar" ],
      "venue" : "Chem. Soc. Rev. 38 ",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Microencapsulation of essential oils within alginate: formulation and in vitro evaluation of antifungal activity",
      "author" : [ "E.A. Soliman", "A.Y. El-Moghazy", "M.S. Mohy El-Din", "M.A. Massoud" ],
      "venue" : "JEAS 3 ",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Antimicrobial activity of essential oils and carvacrol",
      "author" : [ "G. Magi", "E. Marini", "B. Facinelli" ],
      "venue" : "and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A Streptococci, Front. Microbiol. 3 (6) ",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Essential oils loaded in nanosystems: a developing strategy for a successful therapeutic approach",
      "author" : [ "A.R. Bilia", "C. Guccione", "B. Isacchi", "C. Righeschi", "F. Firenzuoli", "M.C. Bergonzi" ],
      "venue" : "Evid. Based Complement. Altern. Med. 2014 ",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Reproducible production of thioacetamideinduced macronodular cirrhosis in the rat with no mortality",
      "author" : [ "X. Li", "I.S. Benjamin", "B. Alexander" ],
      "venue" : "J. Hepatol. 36 ",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Free radicals scavenger and antihepatotoxic activity of Rosmarinus tomentosus",
      "author" : [ "C.M. Navarro", "P.M. Montilla", "A. Martin", "J. Jimenez", "P.M. Utrilla" ],
      "venue" : "Planta Med. 59 ",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 1993
    }, {
      "title" : "Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells",
      "author" : [ "P.J. De Bleser", "G. Xu", "K. Rombouts", "V. Rogiers", "A. Geerts" ],
      "venue" : "J. Biol. Chem. 26 (274) ",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 1999
    }, {
      "title" : "Molecular pathogenesis of alcohol induced hepatic fibrosis",
      "author" : [ "S.V. Siegmund", "D.A. Brenner" ],
      "venue" : "Alcohol. Clin. Exp. Res. 29 ",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Deficiency of nicotinamide adenine dinucleotide phosphate",
      "author" : [ "G. Aram", "J.J. Potter", "X. Liu", "L. Wang", "M.S. Torbenson", "E. Mezey" ],
      "venue" : "reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration, Hepatology 49 ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Nitric oxide and oxygen radicals: a question of balance",
      "author" : [ "V. Darley-Usmar", "H. Wiseman", "B. Halliwell" ],
      "venue" : "FEBS Lett. 369 ",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 1995
    }, {
      "title" : "S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma",
      "author" : [ "C. Maletzki", "P. Bodammer", "A. Breitruck", "C. Kerkhoff" ],
      "venue" : "Hepat. Mon. 12 (10 HCC) ",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity",
      "author" : [ "W. Nacken", "J. Roth", "C. Sorg", "C. Kerkhoff" ],
      "venue" : "Microsc. Res. Tech. 60 ",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Regulation of S100B gene in rat hippocampal CA1 area during long term potentiation",
      "author" : [ "V.O. Pustylnyak", "P.D. Lisachev", "M.B. Shtark", "O.I. Epstein" ],
      "venue" : "Brain Res. 1394 ",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Monocyte chemoattractant protein-1 (MCP-1): an overview",
      "author" : [ "S.L. Deshmane", "S. Kremlev", "S. Amini", "B.E. Sawaya" ],
      "venue" : "J. Interf. Cytokine Res. 29 ",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "V",
      "author" : [ "E. Zamara", "G. Sara", "A. Sara", "P. Ilaria", "A. Manuela", "M. Raffaella", "N. Erica", "B. Cristiana", "M. Stefano" ],
      "venue" : "Francesco, et al., Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice, J. Hepatol. 46 ",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Participation of functionally different macrophage populations and monocyte chemoattractant protein-1 in early stages of thioacetamide-induced rat hepatic injury",
      "author" : [ "Y. Mori", "T. Izawa", "S. Takenaka", "M. Kuwamura", "J. Yamate" ],
      "venue" : "Toxicol. Pathol. 37 ",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes",
      "author" : [ "N. Sakai", "T. Wada", "K. Furuichi", "K. Shimizu", "S. Kokubo", "A. Hara", "J. Yamahana", "T. Okumura", "K. Matsushima", "H. Yokoyama", "S. Kaneko" ],
      "venue" : "J. Leukoc. Biol. 79 ",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Mechanisms of liver fibrosis",
      "author" : [ "S. Tsukada", "C.J. Parsons", "R.A. Rippe" ],
      "venue" : "Clin. Chim. Acta 364 ",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Alphafetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B",
      "author" : [ "Y.R. Liu", "B.B. Lin", "D.W. Zeng", "Y.Y. Zhu", "J. Chen", "Q. Zheng", "J. Dong", "J.J. Jiang" ],
      "venue" : "BMC Gastroenterol. 16 (14) ",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats",
      "author" : [ "B. Aristatile", "K.S. Al-Numair", "C. Veeramani", "K.V. Pugalendi" ],
      "venue" : "Fundam. Clin. Pharmacol. 23 ",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Carvacrol protects against hepatic steatosis in mice fed a highfat diet by enhancing SIRT 1-AMPK signalling",
      "author" : [ "E. Kim", "Y. Choi", "J. Jang", "T. Park" ],
      "venue" : "Evid. Based Complement. Altern. Med. ",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Mechanisms and biomarkers of apoptosis in liver disease and fibrosis",
      "author" : [ "J.B. Chakraborty", "F. Oakley", "M.J. Walsh" ],
      "venue" : "Int. J. Hepatol. ",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Carvacrol ameliorates thioacetamide-induced hepatotoxicity by abrogation of oxidative stress",
      "author" : [ "S. Nafees", "S.T. Ahmad", "W. Arjumand", "S. Rashid", "N. Ali", "S. Sultana" ],
      "venue" : "inflammation, and apoptosis in liver of Wistar rats, Hum. Exp. Toxicol. 1–13 ",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "carvacrol modulates instability of xenobiotic metabolizing enzymes and downregulates the expressions of pcna, mmp-2, and mmp-9 during diethylnitrosamine-induced hepatocarcinogenesis",
      "author" : [ "J. subramaniyan", "G. krishnan", "R. balan", "M.G.J. Divya", "E. Ramasamy", "S. Ramalingam" ],
      "venue" : "in rats, Mol. Cell. Biochem",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2014
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "processes such as metabolism and detoxification of a variety of drugs and xenobiotics [1].",
      "startOffset" : 86,
      "endOffset" : 89
    }, {
      "referenceID" : 1,
      "context" : "Fibrosis is a result of the inadequate tissue repair mechanism that occur following chronic liver injuries including alcohol induced damage, chronic viral hepatitis B or C, parasitic and metabolic diseases [2].",
      "startOffset" : 206,
      "endOffset" : 209
    }, {
      "referenceID" : 2,
      "context" : "If fibrosis is not controlled, it can further be developed into cirrhosis, which eventually ends up with hepatic failure [3].",
      "startOffset" : 121,
      "endOffset" : 124
    }, {
      "referenceID" : 3,
      "context" : "Thioacetamide (TAA) is a well-documented agent that liberates free radicals [4] and is considered as a potent toxic agent for studies concerning the pathogenesis of hepatic fibrosis [4,5].",
      "startOffset" : 76,
      "endOffset" : 79
    }, {
      "referenceID" : 3,
      "context" : "Thioacetamide (TAA) is a well-documented agent that liberates free radicals [4] and is considered as a potent toxic agent for studies concerning the pathogenesis of hepatic fibrosis [4,5].",
      "startOffset" : 182,
      "endOffset" : 187
    }, {
      "referenceID" : 4,
      "context" : "Thioacetamide (TAA) is a well-documented agent that liberates free radicals [4] and is considered as a potent toxic agent for studies concerning the pathogenesis of hepatic fibrosis [4,5].",
      "startOffset" : 182,
      "endOffset" : 187
    }, {
      "referenceID" : 5,
      "context" : "could progress into hepatocarcinomas [6].",
      "startOffset" : 37,
      "endOffset" : 40
    }, {
      "referenceID" : 6,
      "context" : "Several medical reports have stated that tissue transplantation could be the only effective treatment available till now to manage liver fibrosis, however, the continuous progress in studying the biological activities of natural products and herbs have shed light on their potential use for treating hepatic fibrosis [7].",
      "startOffset" : 317,
      "endOffset" : 320
    }, {
      "referenceID" : 7,
      "context" : "Moreover, carvacrol has also been reported to have anti-inflammatory, immunomodulatory and chemopreventive properteis [8,9].",
      "startOffset" : 118,
      "endOffset" : 123
    }, {
      "referenceID" : 8,
      "context" : "Moreover, carvacrol has also been reported to have anti-inflammatory, immunomodulatory and chemopreventive properteis [8,9].",
      "startOffset" : 118,
      "endOffset" : 123
    }, {
      "referenceID" : 9,
      "context" : "Carvacrol is highly lipophilic with low solubility in water [10], high volatile, and with strong odor of essential oil.",
      "startOffset" : 60,
      "endOffset" : 64
    }, {
      "referenceID" : 10,
      "context" : "All these characteristics are the main reasons that make it difficult to be applied in food industry [11].",
      "startOffset" : 101,
      "endOffset" : 105
    }, {
      "referenceID" : 11,
      "context" : "Encapsulation of phytochemicals is one of the most important and interesting applications that enhances their bioavailability by changing the pharmacokinetics and bio-distribution [12] and thus alleviate the drawbacks of their instability, unpleasant flavor or taste and most importantly improve the bioavailability and halflife of the compound through protection of the active compounds against environmental factors (e.",
      "startOffset" : 180,
      "endOffset" : 184
    }, {
      "referenceID" : 12,
      "context" : "g, oxygen, light, moisture, and pH) [13].",
      "startOffset" : 36,
      "endOffset" : 40
    }, {
      "referenceID" : 13,
      "context" : "Recent efforts have led to delivery systems in micro- and nanoscale so that the particular functionality of them has been illustrated based on nanonutrition delivery systems using various natural and synthetic materials [14].",
      "startOffset" : 220,
      "endOffset" : 224
    }, {
      "referenceID" : 14,
      "context" : "[15] the nanoencapsulation deliver system of the essential oil eugenol significantly improved the stability along with the antioxidant and antimicrobial activity of this essential oil comparing to its original form.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 15,
      "context" : "High-energy methods produce intense disruptive forces minimizing droplet size to form emulsions, while low energy methods promote spontaneous emulsification by mixing all the emulsion ingredients [16].",
      "startOffset" : 196,
      "endOffset" : 200
    }, {
      "referenceID" : 16,
      "context" : "Among the most used nanoemulsions; (a) oil in water (O/W) procedure where the droplets of oil are dispersed in an aqueous phase and the interphase is stabilized by emulsifiers, (b) the multiple emulsions procedure oil-in-water-inoil (O/W/O) or water-in-oil-in-water (W/O/W) where for example, minute water droplets immersed inside large oil droplets are in turn dispersed within another aqueous phase; and (c) the multilayer emulsions which is formed as oil droplets surrounded with nanometric size layers of different polyelectrolytes [17].",
      "startOffset" : 536,
      "endOffset" : 540
    }, {
      "referenceID" : 17,
      "context" : "[18] using homogenization model in a matrix comprising of maltodextrin and Tween 20 (T20).",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 18,
      "context" : "Crystallization of the mixture droplets was attained by rapid cooling of the hot nanoemulsions in an ice bath at the end of the HPH processing [19].",
      "startOffset" : 143,
      "endOffset" : 147
    }, {
      "referenceID" : 19,
      "context" : "The Encapsulation Efficiency and loading capacity of the nanoparticles (nano-emulsion and nano-encapsulated carvacrol) were estimated based on the method and equations of Keawchaoon and Yoksan [20] with some modifications.",
      "startOffset" : 193,
      "endOffset" : 197
    }, {
      "referenceID" : 20,
      "context" : "Induction of liver fibrosis Liver fibrosis was induced in albino rats by intraperitoneal injection of thioacetamide (TAA) in a dose of 150 mg/kg body weight twice a week for 6 weeks as described previously [21].",
      "startOffset" : 206,
      "endOffset" : 210
    }, {
      "referenceID" : 21,
      "context" : "Group II (nano-emulsion carvacrol group): healthy rats received nano-emulsion of carvacrol (20 ml/kg body weight/day) orally for 7 days [22].",
      "startOffset" : 136,
      "endOffset" : 140
    }, {
      "referenceID" : 21,
      "context" : "Group III (nano-encapsulated carvacrol group): healthy rats received nano-encapsulated of carvacrol 20 ml/kg body weight/day orally for 7 days [22].",
      "startOffset" : 143,
      "endOffset" : 147
    }, {
      "referenceID" : 22,
      "context" : "Sections of 6 mm thickness were prepared and stained with Haematoxylin and Eosin [23].",
      "startOffset" : 81,
      "endOffset" : 85
    }, {
      "referenceID" : 23,
      "context" : "4) per gram tissue) then centrifuged at 4000 rpm for 15 min at 4 C [24].",
      "startOffset" : 67,
      "endOffset" : 71
    }, {
      "referenceID" : 24,
      "context" : "Biochemical analysis Serum alanine amino transferase (ALT) and aspartate amino transferase (AST) were determined using commercial kit purchased from BioMed Diagnostics based on the method described by Reitman and Frankel [25].",
      "startOffset" : 221,
      "endOffset" : 225
    }, {
      "referenceID" : 29,
      "context" : "EIA-1468) according to the method of Hirai [30].",
      "startOffset" : 43,
      "endOffset" : 47
    }, {
      "referenceID" : 30,
      "context" : "A colorimetric assay was performed according to the method of Patiyal and Katoch [31] for estimation of hydroxyproline content.",
      "startOffset" : 81,
      "endOffset" : 85
    }, {
      "referenceID" : 31,
      "context" : "Phytochemical's encapsulation is an interesting application that enhances their bioavailability by improving the pharmacokinetics and bio-distribution over free compounds and overcoming the drawbacks of instability [32].",
      "startOffset" : 215,
      "endOffset" : 219
    }, {
      "referenceID" : 32,
      "context" : "EOs with moderate water solubility such as cinnamaldehyde can be effectively absorbed in porous polymers and then encapsulated by applying second coating [33].",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 33,
      "context" : "The minimum bactericidal concentration (MBC) was found identical for encapsulated and non-encapsulated carvacrol when tested in culture medium and in simulated gastrointestinal model [34].",
      "startOffset" : 183,
      "endOffset" : 187
    }, {
      "referenceID" : 34,
      "context" : "Nanoencapsulation technique could effectively prevent the loss of EOs in the upper gastrointestinal tract thus increase the proportion of delivered EOs, therefore encapsulated carvacrol can be released nearly completely in the small intestine [35].",
      "startOffset" : 243,
      "endOffset" : 247
    }, {
      "referenceID" : 14,
      "context" : "[15] who were able to prepare both nano-emulsion and nanoencapsulated forms of carvacrol with high encapsulation efficiency and loading capacity and we then investigated their potential therapeutic effect on TAA induced liver fibrosis model.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 35,
      "context" : "TAA induced liver fibrosis in rodents is a documented model with morphological, physiological and biochemical changes similar to human fibrosis [36] and sometimes it induces cirrhosis [21].",
      "startOffset" : 144,
      "endOffset" : 148
    }, {
      "referenceID" : 20,
      "context" : "TAA induced liver fibrosis in rodents is a documented model with morphological, physiological and biochemical changes similar to human fibrosis [36] and sometimes it induces cirrhosis [21].",
      "startOffset" : 184,
      "endOffset" : 188
    }, {
      "referenceID" : 36,
      "context" : "In the present study, TAA injection significantly increased liver enzymes (ALT and AST) in the blood stream which may be related to the leakage of these enzymes from the liver cytosol as a result of alteration in their membrane permeability and transport functions [37].",
      "startOffset" : 265,
      "endOffset" : 269
    }, {
      "referenceID" : 37,
      "context" : "In addition, several studies indicated that increased oxidative stress and reactive oxygen species (ROS) signaling cascade is associated with the activation of hepatic stellate cells (HSC's) [38] that produce ROS as well [39].",
      "startOffset" : 191,
      "endOffset" : 195
    }, {
      "referenceID" : 38,
      "context" : "In addition, several studies indicated that increased oxidative stress and reactive oxygen species (ROS) signaling cascade is associated with the activation of hepatic stellate cells (HSC's) [38] that produce ROS as well [39].",
      "startOffset" : 221,
      "endOffset" : 225
    }, {
      "referenceID" : 39,
      "context" : "The expression of inducible nitric oxide synthase (iNOS) is observed in liver injury, inflammation and fibrosis [40].",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 40,
      "context" : "NO has the ability to react with ROS forming peroxynitrite, a very toxic and oxidizing agent that induce DNA damage and lipid peroxidation [41].",
      "startOffset" : 139,
      "endOffset" : 143
    }, {
      "referenceID" : 41,
      "context" : "Another finding in our study following TAA-induced liver injury is the elevation of S100 calcium-binding protein B (S100B) which is intracellular localized in the cytoplasm and nucleus, whereas it is secreted from epithelial-like cells and tumor cells to increase cellular proliferation and formation of ROS [42] and regulation of inflammatory responses [43], thus S100 B proteins could play an important role in inflammation [44].",
      "startOffset" : 308,
      "endOffset" : 312
    }, {
      "referenceID" : 42,
      "context" : "Another finding in our study following TAA-induced liver injury is the elevation of S100 calcium-binding protein B (S100B) which is intracellular localized in the cytoplasm and nucleus, whereas it is secreted from epithelial-like cells and tumor cells to increase cellular proliferation and formation of ROS [42] and regulation of inflammatory responses [43], thus S100 B proteins could play an important role in inflammation [44].",
      "startOffset" : 354,
      "endOffset" : 358
    }, {
      "referenceID" : 43,
      "context" : "Another finding in our study following TAA-induced liver injury is the elevation of S100 calcium-binding protein B (S100B) which is intracellular localized in the cytoplasm and nucleus, whereas it is secreted from epithelial-like cells and tumor cells to increase cellular proliferation and formation of ROS [42] and regulation of inflammatory responses [43], thus S100 B proteins could play an important role in inflammation [44].",
      "startOffset" : 426,
      "endOffset" : 430
    }, {
      "referenceID" : 44,
      "context" : "Inflammation is also confirmed in our work following TAA administration by the elevation of MCP-1, which is one of the key chemokines that could potentially regulate migration and infiltration of monocytes/ macrophages to certain organ in response to inflammation [45].",
      "startOffset" : 264,
      "endOffset" : 268
    }, {
      "referenceID" : 45,
      "context" : "In the liver, increased MCP-1 expression has been reported in patients with acute and chronic inflammatory diseases and in rodent model liver of injury [46].",
      "startOffset" : 152,
      "endOffset" : 156
    }, {
      "referenceID" : 46,
      "context" : "[47] indicated that MCP-1 mRNA was highly expressed in TAA induced liver injury rat model, suggesting that the increase of MCP-1 at early stages could prompt macrophage infiltration into injured areas.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 47,
      "context" : "In addition to the chemotaxis effect, MCP-1 also plays an important role in fibrogenesis [48].",
      "startOffset" : 89,
      "endOffset" : 93
    }, {
      "referenceID" : 48,
      "context" : "Another important characteristic of liver fibrosis and cirrhosis is the accumulation of extracellular matrix proteins, particularly collagen [49], and this could explain the significant elevation that we detected in the levels of hydroxyproline, the amino acid unique to all collagens, in our TAA injected model.",
      "startOffset" : 141,
      "endOffset" : 145
    }, {
      "referenceID" : 49,
      "context" : "This was also associated with elevation of alpha fetoprotein (AFP), the well known liver inflammation and fibrosis marker and also tumor marker of hepatocellular carcinoma (HCC) [50].",
      "startOffset" : 178,
      "endOffset" : 182
    }, {
      "referenceID" : 7,
      "context" : "It has been previously reported that carvacrol could effectively scavenge superoxide radicals and H2O2 and therefore increase antioxidant enzymes and decrease the free radical mediated inactivation of enzyme proteins and thus maintain the activity of endogenous antioxidant enzyme and improve GSH level [8].",
      "startOffset" : 303,
      "endOffset" : 306
    }, {
      "referenceID" : 8,
      "context" : "Carvacrol has been previously reported to have antiinflammatory effects by reducing the production of inflammatory mediators such as IL-1a and prostanoids [9].",
      "startOffset" : 155,
      "endOffset" : 158
    }, {
      "referenceID" : 51,
      "context" : "[52] confirmed these results and indicated that carvacrol mediated reduction in the expression of pro-inflammatory cytokines and plasma MCP1 and TNF-a concentrations in the liver of mice fed with high-fat diet which may be contributed to decreased infiltration of macrophage into the liver.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 52,
      "context" : "Uncontrolled liver injury leading to fibrosis is characterized by enhancement in the apoptotic death of hepatocytes [53], this was supported in our study by the significant elevation in the level of caspase-3 in TAA injected group comparing to control group.",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 53,
      "context" : "[54] also reported that carvacrol prevented the elevation in apoptosis induced by TAA administration; through pretreatment with carvacrol that showed a protective effect against the deteriorative effect of TAA through reducing oxidative stress, inflammation and apoptosis.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 54,
      "context" : "[55] also reported a potential anti-carcinogenic efficiency of carvacrol through inhibiting cell proliferation and preventing metastasis in diethylnitrosamine- induced hepatocellular carcinomas.",
      "startOffset" : 0,
      "endOffset" : 4
    } ],
    "year" : 2017,
    "abstractText" : "Objective: The present study aimed to compare the therapeutic efficiency of nano-encapsulated and nano-emulsion carvacrol administration on liver injury in thioacetamide (TAA) treated rats. Methods: To fulfill our target, we used sixty male albino rats classified into six groups as follow: control, nano-encapsulated carvacrol, nano-emulsion carvacrol, thioacetamide, treated nano-encapsulated carvacrol and treated nano-emulsion carvacrol groups. Blood samples were collected from all groups and the separated serum was used for analysis of the following biochemical parameters; aspartate aminotransferase (AST), alanine aminotransferase (ALT), S100 B protein, alpha fetoprotein (AFP) and caspase-3. The levels of malondialdehyde (MDA), reduced glutathione (GSH), nitric oxide (NO), monocyte chemoattractant protein-1(MCP-1) and hydroxyproline content were all evaluated in liver tissue homogenate. Histopathological examinations for liver tissues were also performed. Results: Thioacetamide induced hepatic damage in rats as revealed by the significant increase in the levels of serum ALT, AST and produced oxidative stress as displayed by the significant elevation in the levels of hepatic MDA and NO concomitant with a significant decrease in GSH. In addition, thioacetamide significantly increased serum S100B protein, alpha fetoprotein and caspase-3 along with hepatic MCP-1 and hydroxyproline; these results were confirmed by the histopathological investigation. In contrast, nano-encapsulated and nano-emulsion carvacrol were able to ameliorate these negative changes in the thioacetamide injected rats. However, the effect of the nano-encapsulated form of carvacrol was more prominent than the nano-emulsion form. Conclusion: Nano-encapsulated and nano-emulsion carvacrol can ameliorate thioacetamide induced liver injury. These results could be attributed to the potential anti-inflammatory, antioxidant, and antiapoptotic activities of carvacrol in addition to the effectiveness of the encapsulation technique that can protect carvacrol structure and increase its efficiency and stability. Moreover, nano-encapsulation of carvacrol is more efficient than nano-emulsion. © 2017 Elsevier Masson SAS. All rights reserved. Available online at",
    "creator" : "Elsevier"
  }
}